Key Highlights
- Veea (NASDAQ:VEEA) was trading up 8.54% at USD 4.83 on Thursday, November 19, 2026, in intraday market data, implying a prior close near USD 4.45 (calculated), with no company announcement explaining the move found.
- Third-quarter net sales were USD 72,135 against USD 144,926 a year earlier, and the quarter produced a net loss of USD 3.66 million versus Net Income of USD 1.38 million.
- Cash was USD 530,589 and cash plus restricted cash was about USD 1.59 million at September 30, 2026, against an accumulated Deficit of USD 236.8 million.
- The filing cites USD 17.1 million of Debt in its Liquidity section, while the debt note shows USD 13.65 million of principal, so the figure is shown as a range.
A Low-Priced Move With No Announcement Behind It
Veea (NASDAQ:VEEA) was trading up 8.54% at USD 4.83 in intraday market data on Thursday, November 19, 2026. No company announcement explaining the move was found for November 17 to November 19. The shares are low-priced, with a sub-USD 5 quote, and a small number of trades can move the price, spreads can be wide and quoted gains can reverse. The company reported 4,071,515 common shares outstanding as of November 10, 2026, which at USD 4.83 gives a Market Value near USD 19.7 million (calculated). The most recent corporate news found was a September 14, 2026 non-binding term sheet for a combination with NovaGen Group B.V., a regenerative medicine firm based in Amsterdam, with no financial terms disclosed.
What Veea Sells and What the Quarter Showed
Veea develops hybrid edge-cloud computing and edge AI products, including the VeeaONE software platform, VeeaHub access devices and VeeaCloud management, with 121 granted patents. It targets fixed wireless and managed Wi-Fi for service providers and industrial uses such as smart buildings and warehouses. Third-quarter net sales fell to USD 72,135, though nine-month sales rose to USD 428,773 from USD 232,094. The nine-month net loss was USD 12.36 million versus USD 1.74 million a year earlier. The third-quarter swing from a USD 1.38 million profit a year ago to a USD 3.66 million loss shows how small Revenue is against the cost base.
Debt, Listing Status and the NovaGen Term Sheet
Liquidity is the central risk. Cash was USD 530,589 at September 30, 2026, and the filing cites USD 17.1 million of debt, including a USD 10.6 million term Loan and USD 3.4 million of related-party notes, although the debt note shows USD 13.65 million of principal. The company moved to the Nasdaq Capital Market in April 2026, completed a 1-for-20 Reverse Stock Split effective August 28, 2026, and said it regained compliance with listing standards. The NovaGen term sheet targeted a definitive agreement within weeks of September 16, and the filing gave no assurance a deal will be signed or completed. Further financing or share issuance could dilute holders.
Where Things Stand
The 8.54% rise has no verified company-specific cause, so it is best read as a low-priced share moving on thin trading rather than on fundamentals. Veea (NASDAQ:VEEA) reported a USD 3.66 million third-quarter loss, revenue of USD 72,135 and about USD 1.59 million of cash and restricted cash, while its NovaGen term sheet remains non-binding. Next markers are a definitive agreement or its failure, any new financing, and fourth-quarter results. Quoted gains can reverse quickly at this price.






Please wait processing your request...